Graham Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Graham Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$278K	Buy	2,892 +344	+14%	+$35.3K	0.01%	927
2026 Q1	$278K	Sell	2,548 -2,502	-50%	-$238K	0.01%	843
2025 Q4	$410K	Sell	5,050 -2,089	-29%	-$180K	0.01%	711
2025 Q3	$625K	Sell	7,139 -2,286	-24%	-$204K	0.01%	536
2025 Q2	$783K	Buy	9,425 +2,178	+30%	+$182K	0.01%	661
2025 Q1	$608K	Buy	7,247 +1,757	+32%	+$163K	0.01%	729
2024 Q4	$506K	Buy	+5,490	New	+$528K	0.01%	731

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Graham Capital Management's LMAT Position: Q2 2026 in Review

Graham Capital Management increased its LeMaitre Vascular (LMAT) stake by 14% in Q2 2026, buying an estimated $35.3K and bringing the position to 2,892 shares worth $278K. The position accounts for 0.01% of the portfolio, ranked #927.

Graham Capital Management first reported a position in LMAT in Q4 2024 and has held it in 7 quarters since. The position peaked at $783K in Q2 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Graham Capital Management held 2,892 shares of LeMaitre Vascular worth $278K as of Q2 2026.
Graham Capital Management bought 344 LeMaitre Vascular shares in Q2 2026, an estimated $35.3K.
LeMaitre Vascular made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #927 holding.
Graham Capital Management first reported a position in LeMaitre Vascular in Q4 2024 and has held it in 7 quarters since.
Graham Capital Management's LeMaitre Vascular position peaked at $783K in Q2 2025.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.